- Home
- ENTX vs WETO Comparison
ENTX vs WETO Comparison
Compare ENTX & WETO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTX
- WETO
- Stock Information
- Founded
- ENTX 2010
- WETO 2019
- Country
- ENTX Israel
- WETO China
- Employees
- ENTX N/A
- WETO N/A
- Industry
- ENTX Biotechnology: Biological Products (No Diagnostic Substances)
- WETO
- Sector
- ENTX Health Care
- WETO
- Exchange
- ENTX Nasdaq
- WETO NYSE
- Market Cap
- ENTX 104.0M
- WETO 88.0M
- IPO Year
- ENTX 2018
- WETO 2025
- Fundamental
- Price
- ENTX $1.94
- WETO $2.71
- Analyst Decision
- ENTX Strong Buy
- WETO
- Analyst Count
- ENTX 1
- WETO 0
- Target Price
- ENTX $10.00
- WETO N/A
- AVG Volume (30 Days)
- ENTX 35.9K
- WETO 2.0M
- Earning Date
- ENTX 05-09-2025
- WETO 01-01-0001
- Dividend Yield
- ENTX N/A
- WETO N/A
- EPS Growth
- ENTX N/A
- WETO N/A
- EPS
- ENTX N/A
- WETO N/A
- Revenue
- ENTX $223,000.00
- WETO $5,350,773.00
- Revenue This Year
- ENTX N/A
- WETO N/A
- Revenue Next Year
- ENTX N/A
- WETO N/A
- P/E Ratio
- ENTX N/A
- WETO N/A
- Revenue Growth
- ENTX N/A
- WETO N/A
- 52 Week Low
- ENTX $1.41
- WETO $1.50
- 52 Week High
- ENTX $2.79
- WETO $4.30
- Technical
- Relative Strength Index (RSI)
- ENTX 47.15
- WETO N/A
- Support Level
- ENTX $1.69
- WETO N/A
- Resistance Level
- ENTX $2.08
- WETO N/A
- Average True Range (ATR)
- ENTX 0.13
- WETO 0.00
- MACD
- ENTX -0.02
- WETO 0.00
- Stochastic Oscillator
- ENTX 58.14
- WETO 0.00
About ENTX Entera Bio Ltd.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.
About WETO WEBUS INTERNATIONAL LIMITED
Webus International Ltd operates on a business model of Mobility-as-a-Service to identify and solve inefficiencies associated with inflexible or low-quality public transportation and provide cost-efficient and customized mass transportation services under different scenarios with comprehensive digital platforms. It offers commute shuttle service, customized chartered bus service, packaged tour service and other service to customers.